HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Stohl Selected Research

Hypergammaglobulinemia (Hyperimmunoglobulinemia)

7/2012Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.
7/2008Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Stohl Research Topics

Disease

38Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 08/2002
13Rheumatoid Arthritis
01/2021 - 01/2006
6Autoimmune Diseases (Autoimmune Disease)
12/2022 - 10/2002
5Infections
01/2022 - 02/2014
5Inflammation (Inflammations)
01/2020 - 10/2006
4Neoplasms (Cancer)
02/2024 - 08/2002
4Rheumatic Diseases (Rheumatism)
12/2019 - 10/2006
3Arthritis (Polyarthritis)
11/2023 - 04/2003
3Lupus Nephritis
01/2023 - 01/2009
3Proteinuria
01/2020 - 05/2012
2Opportunistic Infections (Opportunistic Infection)
02/2021 - 08/2002
2Tetanus
05/2014 - 08/2012
2Hypergammaglobulinemia (Hyperimmunoglobulinemia)
07/2012 - 07/2008
2Nephritis
02/2009 - 01/2009
1Pre-Eclampsia (Preeclampsia)
01/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2023
1Spontaneous Abortion (Miscarriage)
10/2021
1Skin Neoplasms (Skin Cancer)
02/2021
1Hypersensitivity (Allergy)
02/2021
1Melanoma (Melanoma, Malignant)
02/2021
1Chronic Disease (Chronic Diseases)
01/2018
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2018
1Fatigue
01/2018
1Dacryocystitis (Dacryoadenitis)
07/2014
1Human Influenza (Influenza)
08/2012
1Glomerulonephritis
04/2011
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
11/2009
1Interstitial Nephritis (Tubulointerstitial Nephritis)
07/2008
1Stroke (Strokes)
10/2006
1Starvation
10/2006
1Disease Progression
09/2002

Drug/Important Bio-Agent (IBA)

19B-Cell Activating FactorIBA
11/2022 - 08/2002
18belimumabIBA
01/2023 - 01/2008
12Immunoglobulin G (IgG)IBA
01/2022 - 08/2002
11AutoantibodiesIBA
02/2021 - 08/2002
7Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2009
5Monoclonal AntibodiesIBA
01/2023 - 10/2006
5Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2002
5AntibodiesIBA
12/2019 - 03/2006
4CytokinesIBA
01/2020 - 01/2010
4Rituximab (Mabthera)FDA Link
01/2020 - 03/2006
3Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 03/2012
3AntigensIBA
12/2019 - 02/2010
3EnzymesIBA
09/2015 - 04/2003
3ImmunosorbentsIBA
09/2015 - 04/2003
3DNA (Deoxyribonucleic Acid)IBA
07/2012 - 08/2008
3Messenger RNA (mRNA)IBA
11/2009 - 12/2003
3Estrogens (Estrogen)FDA Link
09/2009 - 08/2008
2Protein Isoforms (Isoforms)IBA
01/2023 - 01/2006
2JNJ-55920839IBA
04/2021 - 10/2020
2Interferon Type IIBA
10/2020 - 02/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 02/2010
2LigandsIBA
12/2019 - 10/2002
2Immunoglobulin M (IgM)IBA
12/2019 - 05/2014
2Tumor Necrosis Factor InhibitorsIBA
03/2017 - 02/2010
2B-Cell Activation Factor ReceptorIBA
09/2015 - 04/2013
2VaccinesIBA
08/2012 - 07/2012
2Antigen-Antibody Complex (Immune Complex)IBA
02/2010 - 10/2006
1Immune Checkpoint InhibitorsIBA
02/2024
1N-acetyltalosaminuronic acid (NAT)IBA
11/2023
1Prolactin Receptors (Prolactin Receptor)IBA
01/2023
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2022
1GLPG0634IBA
01/2021
1Member 25 Tumor Necrosis Factor ReceptorsIBA
01/2020
1C-Reactive ProteinIBA
12/2019
1Serum GlobulinsIBA
12/2019
1GlobulinsIBA
12/2019
1Secretory Immunoglobulin A (SIgA)IBA
01/2018
1ProgranulinsIBA
03/2017
1AMG623 peptibodyIBA
08/2015
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
05/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2014
1Antirheumatic Agents (DMARD)IBA
02/2013
1ocrelizumabIBA
08/2012
1Complement System Proteins (Complement)IBA
07/2012
1Interleukin-4 (Interleukin 4)IBA
04/2011
1CalciumIBA
04/2011
1Interferon-betaIBA
02/2010
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
02/2009
1anti-dsDNA autoantibodyIBA
02/2009
1Complement Factor B (Factor B)IBA
01/2008
1IsomerasesIBA
10/2006
1N 30IBA
01/2006

Therapy/Procedure

10Therapeutics
02/2024 - 10/2006
1Biological Therapy
12/2013